Pacific Biosciences Of California (PACB) Acquisitions (2021)
Pacific Biosciences Of California's (PACB) quarterly Acquisitions came in at $291.2 million in Q4 2021.
Pacific Biosciences Of California (PACB) Acquisitions (2021) Analysis & Trends
Pacific Biosciences Of California's Acquisitions history runs 1 years deep, the most recent figure standing at $291.2 million for Q4 2021.
- On a quarterly basis, Acquisitions changed N/A year-over-year to $291.2 million in Q4 2021; TTM through Dec 2024 was $291.2 million, a N/A change from a year earlier, with the FY2023 full-year figure at $102000.0, changed N/A from the prior year.
- Acquisitions held at $291.2 million in Q4 2021 per PACB's latest filing.
- Across five years, Acquisitions topped out at $291.2 million in Q4 2021 and bottomed at $291.2 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 22.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 406.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 523.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -268.10 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.30 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Pacific Biosciences Of California | 428.15 Mn | 152.18 Mn | 12.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 291.23 Mn |